American Healthcare REIT (AHR) Insider Streiff Buys 2,594 Shares

Mathieu Streiff added 2,594 shares of American Healthcare REIT, Inc. (NYSE:AHR) to his holdings on June 24, 2026. This purchase was part of a significant day of activity for the company's leadership, with multiple insiders reporting new stakes in the Irvine-based real estate firm. Streiff's acquisition was disclosed in a filing with the SEC, though the specific purchase price for this transaction was not listed.

Broad Insider Confidence at American Healthcare REIT

The move by Streiff wasn't an isolated event. On June 24, a group of insiders made identical purchases of 2,594 shares each. This group included Valerie Richardson, Smith Wilbur III, Marvin O'Quinn, Dianne Hurley, and Brian Flornes. While most were buying, one executive took a different path. Mark Foster, the company's Executive Vice President and General Counsel, sold 2,500 shares on the same day at a price of $48.58 per share, a trade worth $121,450. None of these trades were part of a Rule 10b5-1 plan, which are pre-scheduled trading arrangements used to avoid insider trading concerns.

American Healthcare REIT Stock Performance

Shares of American Healthcare REIT were trading around $51.48 on Saturday. The stock has stayed mostly above its 200-day moving average of $50.88, which is a common technical signal that the long-term trend remains positive. Over the past year, the stock has traded between $40.00 and $58.70. With a price-to-earnings (P/E) ratio of 76.91, the market is pricing in expectations for future growth, especially compared to the forward P/E of 52.83, which looks at expected earnings over the next year.

Recent Earnings and Revenue Growth

In its most recent financial reports, the company posted annual revenue of $2.50 billion. That is a 24.7% increase compared to the previous period, showing a healthy expansion in its property portfolio. The company's net margin stands at 4.83%, and it reported a return on equity of 3.95%. For investors looking ahead, the next big financial update is expected when the company reports earnings on November 5, 2026.

Dividend Income for Shareholders

The company currently pays an annual dividend of $1.00 per share. At recent prices, that works out to a dividend yield of 1.92%. This payout represents about 147% of the company's earnings, which is a high payout ratio, though it is not uncommon for REITs to pay out a large portion of their cash flow to maintain their tax-advantaged status.

Analysts Set New Price Targets

Wall Street firms have been active in updating their views on American Healthcare REIT. On October 13, 2026, UBS maintained a Buy rating with a $62.00 target, while Barclays kept an Overweight rating but lowered its target from $66.00 to $60.00. Raymond James also weighed in on that day, initiating coverage with a Strong Buy rating and a $62.00 price target. Earlier in the fall, Scotiabank raised its target to $62.00, and Keybanc lifted its target to $68.00. Overall, 15 analysts cover the stock with a consensus of Strong Buy and a mean price target of $64.40.

About American Healthcare REIT

American Healthcare REIT owns and manages clinical real estate, specifically focusing on senior housing, nursing facilities, and medical office buildings. They operate across the United States and the United Kingdom. The company's strategy involves owning properties that generate steady income from healthcare services, a sector that often sees consistent demand regardless of the broader economy. This business model is likely why so many insiders chose to increase their stakes simultaneously.

Looking Forward

Investors should keep an eye on the November earnings date to see if the company's revenue growth continues to outpace its debt obligations. While the recent insider buying suggests the board is optimistic, 13F filings and insider reports are backward-looking and may not reflect the very latest changes in an insider's portfolio. The high analyst price targets suggest that professional researchers see room for the stock to climb toward the mid-$60 range in the coming months.